Brind.
  1. Bio-Techne is facing scrutiny regarding its market performance and the growth of Protein Sciences, questioned by a UBS analyst.

Protein Sciences accounts for 72% of net sales for Bio-Techne.

2 reports, 1 independent Updated Jul 20
Gone quiet
Reports
2
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Protein Sciences accounts for 72% of net sales for Bio-Techne.

Who's involved

What this event is mainly about
Bio-TechneProtein Sciences

How it developed

Newest first. Tap a step to see who reported it.
  1. The business unit of Protein Sciences is generating cash flows.Sub-event
  2. Protein Sciences reported accounting for 72% of net sales.1 source

Keep exploring

Part of

Bio-Techne is facing scrutiny regarding its market performance and the growth of Protein Sciences, questioned by a UBS analyst. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksBio-Techne Q4 Earnings Preview: What's in Store for the Stock? Bio-Techne Corporation TECH is set to release fourth-quarter fiscal 2025 results on Aug. 6, before the opening bell. The life science an
1 more outlet ran the same wire story